Lomis, N.; Westfall, S.; Farahdel, L.; Malhotra, M.; Shum-Tim, D.; Prakash, S.
Human Serum Albumin Nanoparticles for Use in Cancer Drug Delivery: Process Optimization and In Vitro Characterization. Nanomaterials 2016, 6, 116.
https://doi.org/10.3390/nano6060116
AMA Style
Lomis N, Westfall S, Farahdel L, Malhotra M, Shum-Tim D, Prakash S.
Human Serum Albumin Nanoparticles for Use in Cancer Drug Delivery: Process Optimization and In Vitro Characterization. Nanomaterials. 2016; 6(6):116.
https://doi.org/10.3390/nano6060116
Chicago/Turabian Style
Lomis, Nikita, Susan Westfall, Leila Farahdel, Meenakshi Malhotra, Dominique Shum-Tim, and Satya Prakash.
2016. "Human Serum Albumin Nanoparticles for Use in Cancer Drug Delivery: Process Optimization and In Vitro Characterization" Nanomaterials 6, no. 6: 116.
https://doi.org/10.3390/nano6060116
APA Style
Lomis, N., Westfall, S., Farahdel, L., Malhotra, M., Shum-Tim, D., & Prakash, S.
(2016). Human Serum Albumin Nanoparticles for Use in Cancer Drug Delivery: Process Optimization and In Vitro Characterization. Nanomaterials, 6(6), 116.
https://doi.org/10.3390/nano6060116